By 2023, a popular GLP-1 had become the top-selling medication in the United States , with annual spending on it reaching a staggering $38.6 billion, and the European company behind it is now valued at many hundreds of billions of dollars, becoming one of the most valuable corporations in the European Union
During this probe trial, we recorded the percentage of time spent in the target quadrant (where the platform was previously located), the number of platform location crossings (frequency of swimming over the former platform location), and the latency to first platform crossing
Because of these effects, GLP-1 is a big focus in type 2 diabetes treatment and weight management research
Figure 3 serves as a useful tool to plan the nebulization drug delivery
Rights and permissions About this article Cite this article Sanger, G., Furness, J